Value through Innovation31 October 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

22.05.2012

One million signatures needed to call upon World Health Organisation to save lives through education and improved management of atrial fibrillation

- For NON-US Media Only
22.05.2012

Boehringer Ingelheim announces positive phase II results for once-daily tiotropium in asthma

- For Media outside the U.S., Canada and UK
21.05.2012

Boehringer Ingelheim’s once-daily bronchodilator olodaterol* successfully completes Phase II clinical trial program in COPD

- For Media outside the U.S., Canada and UK
29.04.2012

Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals

- For Non-US and Non-UK Healthcare Media Only
24.04.2012

Boehringer Ingelheim on growth path - Successful 2011 financial year

20.04.2012

GLORIATM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced

- For non-US, UK & Canadian Media
19.04.2012

Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)

- For media outside of the U.S.A. only
19.04.2012

First ever data investigating interferon-free treatment in hepatitis C patients who have liver cirrhosis shows high viral cure rate

- For media outside of the U.S.A. only
18.04.2012

Leading medical and patient organisations join forces to improve stroke prevention in atrial fibrillation

- For NON-US and NON-UK Media Only
18.04.2012

Dabigatran etexilate (Pradaxa®) associated with significantly lower rates of fatal and traumatic intracranial haemorrhage compared with Warfarin

- For Non-US, UK & Canadia Media Only
16.03.2012

Pradaxa® (dabigatran etexilate) – first new oral anticoagulant in nearly 60 years receives final NICE recommendation for stroke prevention in atrial fibrillation in the UK1

- For NON-US, NON-UK & NON- Canadian Healthcare Media Only
12.03.2012

Boehringer Ingelheim sets up its first Asian Veterinary Research & Development Center in Shanghai

02.03.2012

Porcine circovirus research projects from France and Spain awarded

29.02.2012

Boehringer Ingelheim expands capabilities in biopharmaceutical process science

21.02.2012

Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies

03.02.2012

Boehringer Ingelheim, GWT and the TU Dresden sign diabetes research collaboration

31.01.2012

FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes

- For Non-U.S. and Non-UK Media
26.01.2012

Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply